% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{ScannellBryan:137598,
author = {M. Scannell Bryan and M. Argos and I. L. Andrulis and J. L.
Hopper and J. Chang-Claude$^*$ and K. E. Malone and E. M.
John and M. D. Gammon and M. B. Daly and M. B. Terry and S.
S. Buys and D. Huo and O. I. Olopade and J. M. Genkinger and
A. S. Whittemore and F. Jasmine and M. G. Kibriya and L. S.
Chen and H. Ahsan},
title = {{G}ermline {V}ariation and {B}reast {C}ancer {I}ncidence:
{A} {G}ene-{B}ased {A}ssociation {S}tudy and
{W}hole-{G}enome {P}rediction of {E}arly-{O}nset {B}reast
{C}ancer.},
journal = {Cancer epidemiology, biomarkers $\&$ prevention},
volume = {27},
number = {9},
issn = {1538-7755},
address = {Philadelphia, Pa.},
publisher = {AACR},
reportid = {DKFZ-2018-01478},
pages = {1057 - 1064},
year = {2018},
abstract = {Background: Although germline genetics influences breast
cancer incidence, published research only explains
approximately half of the expected association. Moreover,
the accuracy of prediction models remains low. For women who
develop breast cancer early, the genetic architecture is
less established.Methods: To identify loci associated with
early-onset breast cancer, gene-based tests were carried out
using exome array data from 3,479 women with breast cancer
diagnosed before age 50 and 973 age-matched controls.
Replication was undertaken in a population that developed
breast cancer at all ages of onset.Results: Three gene
regions were associated with breast cancer incidence: FGFR2
(P = 1.23 × 10-5; replication P < 1.00 × 10-6), NEK10 (P =
3.57 × 10-4; replication P < 1.00 × 10-6), and SIVA1 (P =
5.49 × 10-4; replication P < 1.00 × 10-6). Of the 151 gene
regions reported in previous literature, 19 $(12.5\%)$
showed evidence of association (P < 0.05) with the risk of
early-onset breast cancer in the early-onset population. To
predict incidence, whole-genome prediction was implemented
on a subset of 3,076 participants who were additionally
genotyped on a genome wide array. The whole-genome
prediction outperformed a polygenic risk score [AUC, 0.636;
$95\%$ confidence interval (CI), 0.614-0.659 compared with
0.601; $95\%$ CI, 0.578-0.623], and when combined with known
epidemiologic risk factors, the AUC rose to 0.662 $(95\%$
CI, 0.640-0.684).Conclusions: This research supports a role
for variation within FGFR2 and NEK10 in breast cancer
incidence, and suggests SIVA1 as a novel risk locus.Impact:
This analysis supports a shared genetic etiology between
women with early- and late-onset breast cancer, and suggests
whole-genome data can improve risk assessment. Cancer
Epidemiol Biomarkers Prev; 27(9); 1057-64. ©2018 AACR.},
cin = {C020},
ddc = {610},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29898891},
pmc = {pmc:PMC6125194},
doi = {10.1158/1055-9965.EPI-17-1185},
url = {https://inrepo02.dkfz.de/record/137598},
}